companies innovating obesity treatment glp-1 drugs 2025 Pharma Giants Bet on Next-Generation Treatments to Sustain Growth Market Overview: GLP-1 Agonists and
Description
Obesity and Type 2 Diabetes has an increasing prevalence worldwide, presenting a major health challenge
.
HSA/FSA
Those who took Ozempic or a similar drug had a 40% lower chance of overdosing on opioids and a 50% lower chance of getting drunk compared to those who didn't take the medication, the study found.
News from food industry suppliers
